In support of this, multivariate analysis, properly adjusted for confounding factors (including the administration of statins, GLP1-RA, and SGLT2-i), revealed water intake, im-IP, and the variations in systemic inflammation and oxidative stress status as variables significantly associated with improvement in hepatic steatosis. The gene discussed is SLC5A2; the disease is Hepatic steatosis.